Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial

Abstract Background Frailty is a state of low physiological reserve and multi-systemic dysregulation that leads to susceptibility to external stressors; it is associated with adverse outcomes. North American data suggest that haemodialysis recipients are more likely to be frail than the general popu...

Full description

Bibliographic Details
Main Authors: Benjamin M. Anderson, Mary Dutton, Edward Day, Thomas A. Jackson, Charles J. Ferro, Adnan Sharif
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Trials
Online Access:http://link.springer.com/article/10.1186/s13063-018-2842-x
id doaj-f5aa58e2f2864a3eadb447464cc7603a
record_format Article
spelling doaj-f5aa58e2f2864a3eadb447464cc7603a2020-11-24T21:46:36ZengBMCTrials1745-62152018-08-011911910.1186/s13063-018-2842-xFrailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trialBenjamin M. Anderson0Mary Dutton1Edward Day2Thomas A. Jackson3Charles J. Ferro4Adnan Sharif5Department of Nephrology, University Hospitals Birmingham NHS Foundation TrustDepartment of Nephrology, University Hospitals Birmingham NHS Foundation TrustNational Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College LondonDepartment of Geriatrics, University Hospitals Birmingham NHS Foundation TrustDepartment of Nephrology, University Hospitals Birmingham NHS Foundation TrustDepartment of Nephrology, University Hospitals Birmingham NHS Foundation TrustAbstract Background Frailty is a state of low physiological reserve and multi-systemic dysregulation that leads to susceptibility to external stressors; it is associated with adverse outcomes. North American data suggest that haemodialysis recipients are more likely to be frail than the general population, although data on UK cohorts are lacking. Furthermore, with a multitude of assessment tools, it is difficult for the clinician to ascertain which is most suitable for this population. The FITNESS Study aims to measure the prevalence and outcomes associated with frailty in a large UK haemodialysis cohort to determine the optimum frailty tool as defined by predictive value for mortality/hospitalisation and to conduct a feasibility study exploring a multi-disciplinary clinical intervention to improve frailty among haemodialysis recipients. Methods/design The study will follow a cohort multiple randomised controlled trial design; the initial cohort study will identify participants to be invited into a subsequent open-label randomised controlled trial. Eligible patients will be identified and recruited from their usual haemodialysis session. They will be invited to complete tasks and questionnaires collecting data on sarcopenia, immunosenescence, mood, cognition, disability, and comorbidity. Fifty pre-frail participants with suitable English proficiency will be randomly selected from this cohort to participate in the randomised controlled trial phase of the study. Further stratified randomisation will occur to assign these 50 participants to active or passive groups. The active group will receive a psychologically supported, patient-centred, multi-disciplinary intervention into frailty, in what we believe to be a first within this patient group. The control group will receive usual haemodialysis standard of care. All participants will be followed up using electronic patient records for outcomes to include hospitalisation and mortality. Primary outcomes for this phase of the study will be feasibility and tolerability of the clinical intervention study. Discussion The study will collect data on multiple aspects of frailty allowing for a rich dataset for detailed analysis. We believe this will be the first study to explore a psychologically supported, patient-centred intervention in this patient group. Trial registration Clinicaltrials.gov, NCT03071107. Registered on 6 March 2017.http://link.springer.com/article/10.1186/s13063-018-2842-x
collection DOAJ
language English
format Article
sources DOAJ
author Benjamin M. Anderson
Mary Dutton
Edward Day
Thomas A. Jackson
Charles J. Ferro
Adnan Sharif
spellingShingle Benjamin M. Anderson
Mary Dutton
Edward Day
Thomas A. Jackson
Charles J. Ferro
Adnan Sharif
Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial
Trials
author_facet Benjamin M. Anderson
Mary Dutton
Edward Day
Thomas A. Jackson
Charles J. Ferro
Adnan Sharif
author_sort Benjamin M. Anderson
title Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial
title_short Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial
title_full Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial
title_fullStr Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial
title_full_unstemmed Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial
title_sort frailty intervention trial in end-stage patients on haemodialysis (fitness): study protocol for a randomised controlled trial
publisher BMC
series Trials
issn 1745-6215
publishDate 2018-08-01
description Abstract Background Frailty is a state of low physiological reserve and multi-systemic dysregulation that leads to susceptibility to external stressors; it is associated with adverse outcomes. North American data suggest that haemodialysis recipients are more likely to be frail than the general population, although data on UK cohorts are lacking. Furthermore, with a multitude of assessment tools, it is difficult for the clinician to ascertain which is most suitable for this population. The FITNESS Study aims to measure the prevalence and outcomes associated with frailty in a large UK haemodialysis cohort to determine the optimum frailty tool as defined by predictive value for mortality/hospitalisation and to conduct a feasibility study exploring a multi-disciplinary clinical intervention to improve frailty among haemodialysis recipients. Methods/design The study will follow a cohort multiple randomised controlled trial design; the initial cohort study will identify participants to be invited into a subsequent open-label randomised controlled trial. Eligible patients will be identified and recruited from their usual haemodialysis session. They will be invited to complete tasks and questionnaires collecting data on sarcopenia, immunosenescence, mood, cognition, disability, and comorbidity. Fifty pre-frail participants with suitable English proficiency will be randomly selected from this cohort to participate in the randomised controlled trial phase of the study. Further stratified randomisation will occur to assign these 50 participants to active or passive groups. The active group will receive a psychologically supported, patient-centred, multi-disciplinary intervention into frailty, in what we believe to be a first within this patient group. The control group will receive usual haemodialysis standard of care. All participants will be followed up using electronic patient records for outcomes to include hospitalisation and mortality. Primary outcomes for this phase of the study will be feasibility and tolerability of the clinical intervention study. Discussion The study will collect data on multiple aspects of frailty allowing for a rich dataset for detailed analysis. We believe this will be the first study to explore a psychologically supported, patient-centred intervention in this patient group. Trial registration Clinicaltrials.gov, NCT03071107. Registered on 6 March 2017.
url http://link.springer.com/article/10.1186/s13063-018-2842-x
work_keys_str_mv AT benjaminmanderson frailtyinterventiontrialinendstagepatientsonhaemodialysisfitnessstudyprotocolforarandomisedcontrolledtrial
AT marydutton frailtyinterventiontrialinendstagepatientsonhaemodialysisfitnessstudyprotocolforarandomisedcontrolledtrial
AT edwardday frailtyinterventiontrialinendstagepatientsonhaemodialysisfitnessstudyprotocolforarandomisedcontrolledtrial
AT thomasajackson frailtyinterventiontrialinendstagepatientsonhaemodialysisfitnessstudyprotocolforarandomisedcontrolledtrial
AT charlesjferro frailtyinterventiontrialinendstagepatientsonhaemodialysisfitnessstudyprotocolforarandomisedcontrolledtrial
AT adnansharif frailtyinterventiontrialinendstagepatientsonhaemodialysisfitnessstudyprotocolforarandomisedcontrolledtrial
_version_ 1725901132886179840